COVID-19 and HIV infection co-pandemics and their impact: a review of the literature

被引：66

作者：

Gatechompol, Sivaporn ^{[1
,2
]}

Avihingsanon, Anchalee ^{[1
,2
]}

Putcharoen, Opass ^{[3
]}

Ruxrungtham, Kiat ^{[4
]}

Kuritzkes, Daniel R. ^{[5
]}

机构：

[1] Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand

[2] Chulalongkorn Univ, Fac Med, TB Res Unit, Bangkok, Thailand

[3] Chulalongkorn Univ, Fac Med, Dept Med, Div Infect Dis, Bangkok, Thailand

[4] Chulalongkorn Univ, Fac Med, Chula Vaccine Res Ctr, ChulaVRC, Bangkok, Thailand

[5] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA

来源：

AIDS RESEARCH AND THERAPY | 2021年 / 18卷 / 01期

基金：

英国科研创新办公室;

关键词：

COVID-19; HIV; Co-infection; Pathophysiology; Clinical; Outcome; CORONAVIRUS; PATHOGENESIS; PEOPLE; SARS;

D O I：

10.1186/s12981-021-00335-1

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Coronavirus disease 2019 (COVID-19) was first detected in December 2019. In March 2020, the World Health Organization declared COVID-19 a pandemic. People with underlying medical conditions may be at greater risk of infection and experience complications from COVID-19. COVID-19 has the potential to affect People living with HIV (PLWH) in various ways, including be increased risk of COVID-19 acquisition and interruptions of HIV treatment and care. The purpose of this review article is to evaluate the impact of COVID-19 among PLWH. The contents focus on 4 topics: (1) the pathophysiology and host immune response of people infected with both SARS-CoV-2 and HIV, (2) present the clinical manifestations and treatment outcomes of persons with co-infection, (3) assess the impact of antiretroviral HIV drugs among PLWH infected with COVID-19 and (4) evaluate the impact of the COVID-19 pandemic on HIV services.

引用

页数：9

共 81 条

[1]

Akalin E, 2020, NEW ENGL J MED, V382, P2475, DOI 10.1056/NEJMc2011117

[2] Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19 [J].